CDMO News Days Hours Minutes Seconds Download Full Agenda CDMO News Recipharm Extends Leganés High-Potency Manufacturing to GMP Pilot Scale Recipharm Extends Leganés High-Potency Manufacturing to GMP Pilot Scale Genezen Partners With Galibra Neuroscience on SSADH Deficiency Gene Therapy Lonza Expands DNA-to-IND Offering to Bispecific Antibodies and Other Biologics Charles River Laboratories Partners With Magellan Stem Cells on Zelestrocel Development Scinai Immunotherapeutics Secures $5.1 Million CDMO Agreement Catalent to Manufacture Mantra’s Single-Serve OTC Oral Gels in Florida Lonza Licenses Qurient’s CDK7 Inhibitors for Dual-Payload ADC Development Bora Biologics Appoints Jennifer Kuan as Chief Executive Officer Perceptive Discovery Partners With Nucleus RadioPharma to Advance Radiopharmaceutical Development Lonza Partners With Onava to Advance AI-Enabled Biologics Discovery CDMO News at CPHI 2026: Speed, Integration and US Capacity More CDMO News Genezen Partners With Galibra Neuroscience on SSADH Deficiency Gene Therapy Lonza Expands DNA-to-IND Offering to Bispecific Antibodies and Other Biologics Charles River Laboratories Partners With Magellan Stem Cells on Zelestrocel Development Scinai Immunotherapeutics Secures $5.1 Million CDMO Agreement Catalent to Manufacture Mantra’s Single-Serve OTC Oral Gels in Florida Lonza Licenses Qurient’s CDK7 Inhibitors for Dual-Payload ADC Development Bora Biologics Appoints Jennifer Kuan as Chief Executive Officer Perceptive Discovery Partners With Nucleus RadioPharma to Advance Radiopharmaceutical Development Lonza Partners With Onava to Advance AI-Enabled Biologics Discovery CDMO News at CPHI 2026: Speed, Integration and US Capacity More CDMO News White Paper[Download] Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report
